These final results, together with a preceding report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two guidance the idea of targeting ACKR3 as a singular solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases. By ticking this box https://horacew814gfa4.blogofchange.com/profile